Medical Evidence

Effects of HemaShock® use in normal volunteers on blood pressure (Fig 1) and amount of blood displaced from the legs to central circulation (Fig 2)

The HemaShock® was kept on each subject for 20 minutes.

For study design and detailed results, including respiratory and biochemical parameters please read the entire paper.

HemaShock® in Hemorrhagic Shock Cases

Preliminary clinical validation of HemaShock® in hemorrhagic shock cases was carried out at the Eisenhower Medical Center, Rancho Mirage, CA, USA.

HemaShock® was placed on 10 patients who presented to the ED, all in critical condition due to massive blood loss. It must be noted that the device was only placed within the hospital setting, and not, as intended, by EMS personnel, i.e. a delay that potentially influences the clinical outcome.


  • 8 out of 10 patients responded to HemaShock® by immediately increasing BP
  • 6 of those were stabilized and able to proceed to the next level of care
  • 3 patients out of the 10 treated cases, were ultimately discharged home

The Figure below briefly summarizes these results.

Medical Evidence articles